COR
Cencora, Inc.
NYSE: COR · Conshohocken, PA · Healthcare
$330.95-6.27 (-1.86%)Closed
Market Cap$63.15B
Cash$2.82Bmost recent
Runway4 mo$2.31B Q burn
P/E (TTM)41.6EPS $7.96
52-Wk Range$251.67 – $372.53
Avg Volume1.5M3-month
Price & Trading Activity

Daily close with catalyst overlays and trading volume

$330.95+42.3%
Pipeline

Drug candidates sponsored by Cencora · ClinicalTrials.gov

0 drugs · 0 trials
No trials found for this sponsor.
Valuation

Risk-adjusted NPV

Loading pipeline…
Peer comparison

Cohort check

No peer cohort defined for COR. Cohorts currently cover gene editing, mRNA, rare-disease gene therapy, and large-cap biotech — more coming soon.